Phoenix Software released updates to its product line in September 2021 EL SEGUNDO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Phoenix Software International, Inc., today announced the general availability of JES3plus V1R1, a derivative work based on IBM’s z/OS® JES3. This release integrates SPOOL I/O performance enhancements made available to JES3plus customers through continuous delivery […]

Read More

Key Companies Covered in the Power Factor Corrector Market Research Report Are ABB Ltd., Eaton Corporation, Schneider Electric, General Electric, NAAC ENERGY CONTROLS, WEG S.A., Texas Instruments Incorporated, TDK Electronics AG, ON Semiconductor Components Industries, LLC, STMicroelectronics, and others., and other key market players. New York, Sept. 28, 2021 (GLOBE NEWSWIRE) — According to the statistics […]

Read More

PHOENIX, Sept. 28, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini Holdings” or the “Company”) (Nasdaq: WSC), a North American leader in turnkey modular space and portable storage solutions, today announced that Brad Soultz, Chief Executive Officer, and Tim Boswell, President & Chief Financial Officer, will join Thompson Research Group for a live […]

Read More

— ENA Respiratory engages PPD, Inc. for Phase 2 COVID-19 post-exposure prophylaxis study and hVIVO for influenza challenge study to assess the efficacy of fast-acting nasal spray designed to boost innate immunity SYDNEY, Australia, Sept. 28, 2021 (GLOBE NEWSWIRE) — ENA Respiratory, a biotechnology company developing a first-in-class nasal spray for the prevention of COVID-19 […]

Read More

U.S. Polo Assn. WEST PALM BEACH, Fla. & POOLE, England, Sept. 28, 2021 (GLOBE NEWSWIRE) — U.S. Polo Assn., the official brand of the United States Polo Association (USPA), in collaboration with its U.K. licensee, Brand Machine Group, was the Official Apparel Partner for the British Beach Polo Championship 2021, played September 17-18 at Sandbanks […]

Read More

GHENT, Belgium, Sept. 28, 2021 (GLOBE NEWSWIRE) — MRM Health, a biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have received regulatory approval from the Federal Agency for Medicines and Health Products (FAMHP) in Belgium to start a Phase 1b/2a trial with the novel next-generation optimized consortium therapy, MH002, in patients […]

Read More